?

Desai Meera J.

Director
Adamis Pharmaceuticals Corporation
US, San Diego [HQ]
CIK 1886559

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
3,138
Price per Share :
$0.78
Equivalence :
$2,447.64

Transaction History

  • A
    Form 4
    3,138 Shares After Transaction
    Value : $n/a
    $0.0
    05/25/23
  • Footnotes:
    #1 On May 22, 2023, Adamis Pharmaceuticals Corporation ("Adamis") effected a 1 for 70 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
    #2 Received in exchange for common stock of DMK Pharmaceuticals Corporation, a privately held corporation ("DMK"), in connection with the merger of DMK into a subsidiary of Adamis (the "Merger"). On the effective date of the Merger, the closing price of Adamis common stock was $2.50 per share.